Placenta-derived mesenchymal stem cells (MSCs) are multipotent stem cells with a high capacity for self-renewal. Placenta mesenchymal stem cells can develop into specialized cells of the body such as chondrocytes, osteoblasts, and adipocytes, and their easy accessibility, exceptional genomic stability, and capacity for tissue repair with few immunological and ethical issues make them a favorable cell type for experimental and clinical use. Furthermore, MSCs derived from neonatal tissues have shown greater proliferative capacity and lower immunogenicity than adult bone marrow-derived MSCs. Human chorionic villi-derived mesenchymal stem cells (hCV-MSCs; isolated from the fetal portion of the placenta) have been shown to exhibit reduced telomere loss and senescence onset delay in vitro, as well as a more heterogeneous cell population than other placental MSCs.
Human placental mesenchymal stem cells were isolated from the chorionic villi of the placenta (female offspring). Human placental cells are cultured, passaged for purity, cryopreserved, and delivered frozen. Each vial contains 1 x 106 cells in 1 mL volume. Human placental MSC are characterized by flow cytometry for CD90, CD105, CD73, CD45, and CD34. hCV-MSCs are negative for mycoplasma, yeast, fungi, and bacteria. HIV-1, HIV-2, and HBV are not detected. Cells are assured to further culture using the protocol provided by JangoCell.
Human chorionic villi-derived mesenchymal stem cells (hCV-MSCs) are also known as: CVMSCs, PMSCs, P-MSCs, pMSCs, PDMPCs, chorionic MSCs, human chorionic-villi-derived MSCs, placenta tissue-derived MSCs, human placental stem cells, stem cells from placenta, and placenta stem cells.
This cell product is intended for laboratory research purposes only. Not approved for use in human subjects or for clinical, diagnostic, or therapeutic use in animals or humans.
Human Material Precaution
Tissues used for cell isolation were acquired with informed consent and adhere to HIPAA standards for human privacy protection. All human biological material, including human cells, should always be handled as potentially infectious using at least Biosafety Level 2 precautions; we recommend that appropriate safety procedures be followed, using the same biosafety protocol used with known infectious material. Viral testing cannot prove the absence of a latent viral genome.
JangoCell Statement on Passage Number
While passage number is the de facto metric used for determining cell proliferation capacity, the actual capacity is dependent upon the total number of cell divisions (or population doubling number (PDN)) that a particular cell type can undergo. This can be illustrated with a simple example. Since stem cells are typically passaged upon reaching confluence, cells grown at low confluence in a flask or in a large vessel such as a bioreactor (large surface area to cell number) will require many more doublings to reach confluence before they are ‘passaged’ than cells seeded at high confluence. This can result in low passage numbers, but a cell population with more limited capacity for further cell division. Therefore, passage number is not the most reliable means of determining future cell proliferation capacity after purchase.
For these reasons, and to provide transparency concerning our cell products, JangoCell will express future cell division capacity, or the number of times that our cells will be able to divide and double in number after purchase (after thaw), in terms of population doubling number (PDN). We will express the current cell division number, or the number of times that our cells have already divided and doubled in number before cryopreservation, in terms of population doubling level (PDL). JangoCell’s primary stem cells when plated at ~20% confluency will display a PDN between 30-40 when cultured using the protocol recommended by JangoCell for each specific cell type.
Please see our page on passage number under Technical Resources for more information.
Contact us for the technical documents on this product.
This product is sent on the condition that the customer is responsible for and assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, and use of the JangoCell product including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. As a condition of receiving the material, the customer agrees that any activity undertaken with the JangoCell product and any progeny or modifications will be conducted in compliance with all applicable laws, regulations, and guidelines. This product is provided ‘AS IS’ with no representations or warranties whatsoever except as expressly set forth herein and in no event shall JangoCell, its parent company, directors, officers, agents, employees, assigns, successors, and affiliates be liable for indirect, special, incidental, or consequential damages of any kind in connection with or arising out of the customer’s use of the product. Any proposed commercial use is prohibited without a license from JangoCell.
Please see the Terms and Conditions of Sale for further details regarding the use of this product at https://www.jangocell.com/about-us/terms-and-conditions/.
Does your published paper include JangoCell products?
If you publish a paper that includes any of our products, tell us and we will reward you with ONE Free JangoCell product.
That’s right – get 100% off a single JangoCell branded item in our store. Simply contact us and we’ll supply you with a coupon code.